HighGravityData
Companies / Labcorp / Filing

Labcorp — Apr 29, 2025 release

Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000920148-25-000054
Open on SEC.gov ↗
Showing in the filing
Quarterly cash dividend
“$0.72 per share”
Period
No period stated
Measure
Declared action
Source
Prose
All guidance in this release · 5
Adjusted EPS range for FY2025
“$15.70 to $16.40”
Free Cash Flow for FY2025
“$1.10 billion to $1.25 billion”
Quarterly cash dividend for Q2 FY2025
“$0.72 per share of common stock”
Quarterly cash dividend
“$0.72 per share”
Next Twelve Months Forecast Backlog Conversion
“$2.56”
Exhibit 99.1 · the passage around this item
… earlier in the release
• Launched eClaim Assist, a next-generation digital platform that introduces smarter workflows to improve efficiencies in billing, payer alignment and denials. On April 10, 2025, Labcorp announced a quarterly cash dividend of $0.72 per share of common stock, payable on June 11, 2025, to stockholders of record at the close of business on May 29, 2025. On April 15, 2025, Labcorp issued its 2024 Corporate Responsibility Report. The report demonstrates how the company is pursuing a healthier future as it advances its mission to improve health and improve lives. 2 LABCORP HOLDINGS INC. CONSOLIDATED RESULTS Three Months Ended March 31, 2025 2024 Delta Revenue Summary (Dollars in billions) Total Revenue $ 3.35  $ 3.18  5.3  % Organic (1) 2.1  % Acquisitions, net of Divestitures 3.7  % Foreign Exchange (0.5  %) (1) Organic revenue is no longer broken out between the Base Business and COVID-19 Testing. Earnings Summary (Dollars in millions, except per share data) Operating Income (“OI”) $ 326.0  $ 321.3  OI as % of Revenue 9.7  % 10.1  % (40) bps Adjustments (2) $ 143.0  $ 131.5  Adjusted Operating Income (“AOI”) (3) $ 469.0  (4) $ 452.8  AOI as % of Revenue 14.0  % 14.3  % (20) bps (5) Net Earnings Attributable to Labcorp Holdings Inc. $ 212.8  $ 228.0  Diluted EPS $ 2.52  $ 2.69  Adjusted EPS (3) $ 3.84  $ 3.68  (2) Adjustments include amortization, impairment charges, restructuring charges, and special items. (3) Non-GAAP f
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.